Starpharma Holdings Ltd banner

Prices of ASX stocks are not being updated. The latest SPL price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Australia AU
Employees
50
IPO date
Sep 28, 2000

Starpharma Holdings Ltd is a biotechnology company that develops and commercializes dendrimer-based products. Its best-known products are its antiviral and antibacterial gels and coatings, including women’s health products and disinfectant or surface-treatment technologies. In simple terms, it uses its chemistry platform to make products that can block germs or carry active ingredients in a more targeted way.

The company sells these products directly in some markets and also licenses its technology to larger pharmaceutical, consumer health, and materials companies. That means it can earn money from product sales, license fees, and royalties when partners use its technology in their own products. Its main customers are healthcare providers, consumers, and corporate partners that need a specialized ingredient or product platform rather than a full drug discovery engine.

What makes Starpharma different is that it sits between a drug developer and a technology supplier. Instead of making a broad range of medicines, it focuses on a proprietary molecular platform that can be adapted for medical, consumer, and industrial uses. This gives the business a mix of direct product revenue and partner-driven revenue, which is common in specialty biotech but less like a traditional drug maker.

Starpharma Holdings Ltd Investor Relations

Address
4-6 Southampton Crescent, Abbotsford
Melbourne, Victoria
Australia

Business Segments

Drug development and licensing

This part of the business develops dendrimer-based medicines and medical products, including treatments and prevention products for infections. Starpharma also works with partners to move these products through testing a...

Customers and revenue model

Consumer health products

This part sells Starpharma-branded products designed for everyday infection prevention, such as personal care and over-the-counter health products that use the company’s technology.

Customers and revenue model

Management

Ms. Cheryl Maley B.Sc., M.B.A.

CEO, MD & Director

Biography unavailable

Mr. Justin Cahill

CFO & Company Secretary

Biography unavailable

1 / 2